What is Scheer Partners?
Operating as a premier full-service commercial real estate entity, Scheer Partners distinguishes itself through deep-rooted expertise in high-barrier sectors such as scientific and biotech facilities, healthcare, and industrial properties. With over thirty years of market presence, the firm provides an integrated suite of services including agency leasing, property management, and project development. Their market position is defined by a client-centric approach that bridges the gap between complex infrastructure requirements and institutional-grade real estate solutions, making them a critical partner for organizations navigating the evolving landscape of the Mid-Atlantic region.
How much funding has Scheer Partners raised?
Scheer Partners has raised a total of $354K across 2 funding rounds:
Debt
$150K
Debt
$204K
Debt (2020): $150K with participation from PPP
Debt (2021): $204K led by PPP
Key Investors in Scheer Partners
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Scheer Partners?
With the recent influx of capital, Scheer Partners is well-positioned to accelerate its strategic growth initiatives, particularly within the high-demand biotech and life sciences real estate segments. The firm is expected to deploy these resources to enhance its project development capabilities and expand its footprint in key urban corridors. By focusing on capital markets and property management optimization, Scheer Partners aims to fortify its competitive advantage, ensuring long-term value creation for its diverse client base while maintaining its reputation for operational excellence in a volatile economic environment.
See full Scheer Partners company page
